Clinical trial
Vorinostat Before Surgery in Treating Patients With Triple-Negative Breast Cancer
NCT01695057
Study timeline
Study start (unknown)2012-10-01Date precision: month
Registry last updated2014-01-28
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Stage II Breast Cancerunresolved
Stage IIIA Breast Cancerunresolved
Triple-negative Breast Cancerunresolved
Interventions
vorinostatDRUG · verified · RxNorm: vorinostat
therapeutic conventional surgeryPROCEDURE
Sponsors & collaborators
University of Southern Californialead sponsor
National Cancer Institute (NCI)collaborator
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01695057 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.